Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
Ponec, D
Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. [electronic resource] - Journal of vascular and interventional radiology : JVIR Aug 2001 - 951-5 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1051-0443
10.1016/s1051-0443(07)61575-9 doi
Catheterization, Central Venous
Catheters, Indwelling
Double-Blind Method
Equipment Failure
Female
Fibrinolytic Agents--administration & dosage
Humans
Male
Middle Aged
Placebos
Thrombosis--drug therapy
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome
Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. [electronic resource] - Journal of vascular and interventional radiology : JVIR Aug 2001 - 951-5 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1051-0443
10.1016/s1051-0443(07)61575-9 doi
Catheterization, Central Venous
Catheters, Indwelling
Double-Blind Method
Equipment Failure
Female
Fibrinolytic Agents--administration & dosage
Humans
Male
Middle Aged
Placebos
Thrombosis--drug therapy
Tissue Plasminogen Activator--administration & dosage
Treatment Outcome